Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.
Synchronised Cardiac Assist i-cor, which the company reports to be the first system that links mechanical circulatory support to the heartbeat.
It was the quiet before the storm. At the end of March, during the American College of Cardiology (ACC) meeting in Washington, the future of renal denervation was about to be decided with the presentation of the Medtronic-funded Simplicity HTN-3 clinical trial.
Biotronik, a leading manufacturer of cardiovascular medical technology, announced CE approval for its new Eluna pacemaker series. The new generation of pacemakers includes single and dual-chamber as well as cardiac resynchronization (CRT-P) devices.
It is the quiet before the storm. At the end of March, the future of renal denevation will be decided with the presentation of the Simplicity HTN-3 clinical trial at the American College of Cardiology meeting in Washington.
Fully implantable mechanical hearts bring hope to 121,000 heart failure patients who will never receive a heart transplant
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that it has received CE Mark in Europe and is initiating the launch of its most advanced transcatheter aortic valve, the Edwards SAPIEN 3 valve.
Despite the availability of cardioversion, ablation and medications to treat AF, outcomes are often poor because it is unclear which patients will benefit most. A new classification of atrial fibrillation (AF) by electrocardiogram (ECG) is set to be developed by European experts to aid personalised management of this devastating condition.
Since minimally invasive surgery (MIS) entered cardiac surgery in the mid-1990s it became unthinkable not to use this medical specialty. However, MIS procedures do not always result in the best outcome for patients.
The Plaque-CharM project funded by the German Federal Ministry of Education and Research is to develop novel sensor technology that can characterise arterial tissue in the smallest space – the tip of a catheter.
Prevention Suite’s four combined imaging technologies enables practical pre-clinical assessment of cardiovascular disease risk .
Ahead of regulatory approval that is expected before the end of the year, Trinity Biotech chose Medica to present the novel point-of-care (POC) analyzer Meritas with the Troponin I (TnI) that are expected to disrupt a €700 million market.
The C-Pulse, manufactured by Australian-American company Sunshine Heart, Inc. is neither a pulsatile artificial heart nor one of the well-known non-pulsatile left heart support systems
In 1839 Richard Thoma was the first to observe that arteries respond to flow: he identified a fundamental relationship between blood flow and arterial calibre.
About 500,000 people in France people suffer heart failure (HF). In Europe the figure is six million and the same in the USA.
‘Cardiology is one of the most innovative medical disciplines. Many modern technologies, such as catheterisations or imaging procedures, were triggered by cardiology,’ declared Professor Dr Gerald Maurer MD.
A new procedure may help people with persistent hypertension. By burning or ablating the nerves in the renal arteries, blood pressure levels can be reduced significantly.
Death rates from cardiac disease have more than halved in many EU countries since the early 1980s, according to new research published in the European Heart Journal.
Each year the case grows stronger for transcatheter aortic valve replacement (TAVI). And it is only six years since the procedure was introduced in Europe.
Cardiologists believe they can restore coronary arteries thanks to a new generation of stents that help the body to strengthen collapsed vessels. Elsewhere, patients’ own stem cells are being programmed to rebuild cardiac muscle in HF patients.
Nothing new has been invented in heart failure in the last 15 years, according to Christian Homsy, CEO of Belgian-based Cardio3 Biosciences. This explains the excitement surrounding an emerging treatment among cardiologists, patients and investors.
An injunction against the sale of Medtronic's CoreValve and CoreValve Evolut systems in Germany went into effect as Edwards Lifesciences posted the bond required the District Court of Mannheim.
The Catharina Hospital (Eindhoven, the Netherlands) and Royal Philips (NYSE: PHG, AEX: PHIA) today announced the results of a clinical study involving the treatment of 136 patients with complex heart rhythm disorders such as atrial fibrillation (AF).
The potential of cardiac magnetic resonance imaging (CMRI) is still largely untapped. One novel application might be ablation follow-up. The first MRI-guided cardiac interventions were performed at Herzzentrum Leipzig, but, as far as coronary imaging is concerned, MDCT remains superior to MRI
Computed tomography (CT) is the modality of choice for many diagnostic issues. Whilst currently its major strength is the visualisation of anatomical detail, future technological improvements may also reduce radiation exposure.
